Clinical trials are the backbone for advancing therapeutic options for patients diagnosed with cancer. Yet only 7.1% of patients with cancer participate in clinical trials in the United States. We review some of the reasons for poor accrual and discuss potential solutions.

中文翻译：

---

癌症新疗法：考验和磨难


临床试验是为诊断为癌症的患者提供治疗选择的支柱。然而在美国，只有 7.1% 的癌症患者参加临床试验。我们回顾了应计收益不佳的一些原因并讨论了潜在的解决方案。